三个队列中体重指数与原发性开角型青光眼的相关性
本多队列观察性研究将PROGRESSA研究中471例疑似或早期原发性开角型青光眼患者的纵向视野进展分析与英国生物银行、加拿大老龄化纵向研究两个复制队列结合,发现较低体重指数与更快的视野进展、更差的垂直杯盘比、更高的青光眼诊断可能性相关,体重指数与眼压呈正相关。
要点
- PROGRESSA研究中,较低体重指数对应更快的视野进展速率(β 0.04 dB/年/标准差,95%CI [0.005, 0.069],P = .013)。
- 英国生物银行中,体重指数每降低1个标准差与更差的横断面垂直杯盘比及约10%更高的青光眼诊断可能性相关。
- 加拿大老龄化纵向研究中,较低体重指数与更大的垂直杯盘比变化相关(β -0.007/标准差,95%CI [-0.01, -0.001],P = .023)。
核心结论
- 体重指数与纵向和横断面青光眼结局相关,支持既往关于体重指数与青光眼相关性的研究。
研究设计与样本
- 多队列观察性研究,结合PROGRESSA研究(疑似或早期原发性开角型青光眼病例的回顾性纵向分析,471例参与者)与英国生物银行、加拿大老龄化纵向研究两个复制队列。
主要发现
- PROGRESSA研究中,较低体重指数对应更快的视野进展速率(平均监测时长5.28 ± 1.80年,10.6 ± 3.59次随访;β 0.04 dB/年/标准差,95%CI [0.005, 0.069],P = .013)。
- 英国生物银行中,体重指数每降低1个标准差与更差的横断面垂直杯盘比相关(β -0.048/标准差,95%CI [-0.056, 0.96],P < .001),并与依据视网膜眼底成像专家分级诊断青光眼的可能性增加10%相关(OR 0.90,95%CI [0.84, 0.98],P = .011)。
- 英国生物银行中,较低体重指数与依据国际疾病分类数据诊断青光眼的更高风险相关(OR 0.94/标准差,95%CI [0.91, 0.98],P = .002)。
- 体重指数与眼压呈正相关(β 0.11/标准差,95%CI [0.06, 0.15],P < .001)。
- 加拿大老龄化纵向研究中,较低体重指数与更大的垂直杯盘比变化相关(β -0.007/标准差,95%CI [-0.01, -0.001],P = .023)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the relationship between body mass index (BMI) and glaucoma progression. DESIGN: Multicohort observational study. METHODS: This study combined a retrospective longitudinal analysis of suspect and early manifest primary open angle glaucoma cases from the Progression Risk of Glaucoma: RElevant SNPs with Significant Association (PROGRESSA) study with 2 replication cohorts from the UK Biobank and the Canadian Longitudinal Study of Ageing (CLSA). In the PROGRESSA study, multivariate analysis correlated BMI with longitudinal visual field progression in 471 participants. The BMI was then associated with glaucoma diagnosis and cross-sectional vertical cup-disc ratio (VCDR) measurements in the UK Biobank, and finally prospectively associated with longitudinal change in VCDR in the CLSA study. RESULTS: In the PROGRESSA study, a lower BMI conferred a faster rate of visual field progression (mean duration of monitoring (5.28 ± 1.80 years (10.6 ± 3.59 visits) (β 0.04 dB/year/SD95% CI [0.005, 0.069]; P = .013). In the UK Biobank, a 1 standard deviation lower BMI was associated with a worse cross-sectional VCDR (β -0.048/SD 95% CI [-0.056, 0.96]; P < .001) and a 10% greater likelihood of glaucoma diagnosis, as per specialist grading of retinal fundus imaging (OR 0.90 95% CI [0.84, 0.98]; P = .011). Similarly, a lower BMI was associated with a greater risk of glaucoma diagnosis as per International Classification of Disease data (OR 0.94/SD; 95% CI [0.91, 0.98]; P = .002). Body mass index was also positively correlated with intraocular pressure (β 0.11/SD; 95% CI [0.06, 0.15]; P < .001). Finally, a lower BMI was then associated with greater VCDR change in the CLSA (β -0.007/SD; 95% CI [-0.01, -0.001]; P = .023). CONCLUSIONS: Body mass index correlated with longitudinal and cross-sectional glaucomatous outcomes. This supports previous work illustrating a correlation between BMI and glaucoma.
引用
- Marshall H, Berry EC, Torres SD, et al. Association Between Body Mass Index and Primary Open Angle Glaucoma in Three Cohorts. Am J Ophthalmol. 2022. PMID: 35970205. doi:10.1016/j.ajo.2022.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。